CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis [Phase 1, Phase 2]
Summary
Panoptes Pharma GmbH completed a Phase 1/2 safety study of intravitreal PP-001 in chronic non-infectious uveitis and posted the results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Panoptes Pharma GmbH | Conditions: Non-infectious Uveitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-09